Article
Author(s):
Toronto - A group of Canadian physicians who use Artecoll, an injectable currently awaiting FDA approval, is calling for the development of formal clinical guidelines and further research to help avoid adverse patient reactions.
Daily Derm Times: March 13, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Mastering Dermoscopy and Dysplastic Nevi
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Mohs Surgery Outperforms Wide Local Excision in SCC Control
National Eczema Association Expands Visual Guide to Address Skin Tone Disparities